The Immunology Market is rapidly evolving with innovations in biologics, vaccines, and immunomodulators. North America dominates due to strong infrastructure, R&D, and favorable policies. Europe and Asia-Pacific are emerging markets benefiting from increased healthcare awareness and expenditure. Companies focus on developing personalized therapies and monoclonal antibodies to address ... https://www.marketresearchfuture.com/reports/immunology-market-30261